On June 1, 2008, the United
States Pharmacopeia (USP)
General Chapter 797 Pharmaceutical
Compounding – Sterile Compounding
(USP ) was made official. Read More ›
Although the role of biosimilars in the treatment of patients with cancer has been under review by payers and providers for several years, there remains conflicting application regarding policy and strategy. Read More ›
